New studies have proven that stem cell transplantation is much more effective than mitoxantrone for multiple sclerosis patients and their brain lesion. Italian researchers show that after undergoing stem cell treatments, patients had a lot less brain lesions than those on mitoxantrone. The reduction of new T2 lesion was astonishing 79%.
Giovanni Mancardi and his team from the University of Genova in Italy worked on this study for 4 years, whilst receiving support from the Italian Multiple Sclerosis Foundation. The focus was not on the later benefits of the stem cell treatment, but they found it evident that alongside fewer brain lesions, patients have less relapses annually, as well. The team believes that this treatment could easily be a lot more superior compared to the current treatments that are widely used for dealing with multiple sclerosis. It is also an option for all the patients who don’t respond to other treatments, said the team.
21 patients from seven Italian and Spanish centers participated in this research. Their average age was 35 and all of them had either relapsing-remitting or secondary progressive multiple sclerosis. They were randomized to intensive immunosuppression followed by either mitoxantrone or autologous hematopoietic stem cell transplantation every month for 6 months.
Median of T2 lesions were 2.5 versus 8, when comparing stem cell treatment with mitoxantrone, making stem cell treatment significantly more successful. Relapses also decreased more with stem cell treatment than it did with mitoxantrone.
This research is still not finished, and the team will proceed to phase III trial. They hope that their work helps the stem cell therapy become widely licensed worldwide.
Testimonials
What they say about us
Shaun Lawrence battled multiple sclerosis for many years before deciding to come to Swiss Medica clinic. Limp on his right leg, urinary and bowel problems were some of the main issues he suffered from. After having a stem cell treatment his life changed completely. He is very satisfied with the experience, as well as the overall results of the treatment.
continueFor me, since I got back after my 2 weeks of having my treatment, within 2 days of being home speaking to friends and family around the world, they all noticed the difference in my speaking, cognitively and I was able to listen and integrate with conversations with my family at home.
A wonderful experience, a wonderful care are these very caring people, yes.
continueEverything is done naturally and pleasantly here. Actually I do not feel sick, it is the most important thing – during these 12 days I haven’t felt sick.
I didn’t have the impression that I was treated like a patient. I was treated like a normal person, it is true I take medicines, receive infusions and still have some pain, but I never felt like I was in the hospital.
continueLinda Cole struggled with multiple sclerosis for over 30 years. She decided to give stem cell treatment a try, even though she didn’t expect much from it. She was pleasantly surprised, as her symptoms improved and reversed drastically. Her ability to move, walk and think much better than before assured her she made the right decision by coming to Swiss Medica.
continueAll form fields are required.